Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
SLXN Silexion Therapeutics
- 1.030
- +0.327+46.51%
Close Apr 23 16:00 ET
- 0.987
- -0.043-4.17%
Post 20:01 ET
8.95MMarket Cap-0.12P/E (TTM)
1.290High0.759Low67.15MVolume0.759Open0.703Pre Close74.09MTurnover1283.52%Turnover RatioLossP/E (Static)8.69MShares122.01852wk High-2.24P/B5.39MFloat Cap0.57552wk Low--Dividend TTM5.23MShs Float122.013Historical High--Div YieldTTM75.55%Amplitude0.575Historical Low1.103Avg Price1Lot Size
About Silexion Therapeutics Company
Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.
Company Profile
SymbolSLXN
Company NameSilexion Therapeutics
Listing DateApr 9, 2021
Founded2008
CEOMr. Ilan Hadar
MarketNASDAQ
Employees14
Fiscal Year Ends12-31
Address12 Abba Hillel Road
CityRamat-Gan
ProvinceTel Aviv
CountryIsrael
Zip Code5250606
Phone972-8-628-6005
Websitehttp://silexion.com/
Company Executives
- Name
- Position
- Salary
- Ilan Hadar
- Chairman of the Board and Chief Executive Officer
- 1.54M
- Mirit Horenshtein Hadar
- Executive Vice President, Finance Affairs, Chief Financial Officer and Secretary
- 770.09K
- Dr. Mitchell Shirvan
- Chief Scientific and Development Officer
- 1.30M
- Professor Amnon Peled, PhD
- Independent Director
- --
- Ruth Alon
- Independent Director
- 45.00K
- Shlomo Noy
- Independent Director
- 313.80K
- Ilan Levin
- Independent Director
- --
- Dror J. Abramov
- Independent Director
- 313.80K
- Avner Lushi
- Independent Director
- 313.80K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now